Dapirolizumab Antibody
Dapirolizumab pegol is a PEGylated Fab' anti-CD40L antibody fragment investigated for the treatment of systemic lupus erythematosus (SLE) . It modulates T cell-dependent B cell responses and has been evaluated in both in vitro assays and clinical trials to assess its therapeutic potential in autoimmune diseases.
Product Specifications
Target
TNF
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Cell Biology
Concentration
5.27 mg/mL
Purity
99.40% (May vary between batches)
Molecular Weight
150 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1588155-01 0.1 mg
Recombinant HSV-1/HHV-1 TRX2/UL18 Protein, N-GST & C-His
Sign In for Pricing
View Details